WHAT IT IS, CHALLENGES FOR PUBLIC HEALTH OFFICIALS, HOW TO PREVENT IT
24 July 2009
Abstract
Hippocrates once described a common illness as “phthisis,” which today is believed to have been the same disease we now call tuberculosis, or TB. Many centuries have passed since Hippocrates, and TB has been a major scourge to humans as well as other species. In the early 20th Century, TB was called “consumption” or “White Plague”, which was rated as the number one killer of Canadians. For many centuries, the “White Plague” continued to be a menace due to individual’s lack of understanding of the disease and the improper medical equipment and medicines to help fight it. However, the understanding of TB combined with the sophisticated medicines today, allow the United States (US) to have the upper hand on this once feared disease. Over the past few decades, the US has claimed victory against TB thanks to vast medical science and research. The nation can be fearless of TB not because of the disease disappearance but due to the ability of it to being cured!
Multidrug-Resistant Tuberculosis in the United States:
What It Is, Challenges for Public Health Officials, How to Prevent
Prior to the introduction of anti-tuberculosis drugs in the 1950s, patients had no treatment for TB disease. This meant that the mortality for the individuals with pulmonary disease (Active TB) was about 50%. With years of scientific research, improvements for various drug therapies increased the vitality rate to 98 % by the 1980s.[1] The first full implementation of nationwide reporting of TB didn’t occur until 1953. In 2006, the United States (US) reported 13,767 new tuberculosis cases; this was a 3.2% decrease from the 14,093 new cases in 2005.[2],[3] In 2005, there was 124 cases where individuals were infected with a multi-drug resistant tuberculosis